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ABSTRACT 
DIAGNOSTIC ABILITY OF OTO-ACOUSTIC  EMISSION AND BRAIN 
STEM EVOKED  RESPONSE AUDIOMETRY IN HEARING 
 SCREENING OF HIGH RISK NEWBORN 
BACKGROUND AND OBJECTIVES : 
Early detection of hearing impairment is crucial for normal social and emotional 
development  . Prevalence of deafness estimated by various studies in newborn is 
1.6 per 1000. Objective of the study is to compare the diagnostic ability of Oto-
acoustic Emission and brainstem evoked response audiometry in hearing screening 
of high risk infants.To determine the ideal hearing screening tool in high risk 
newborn and the referral rate of OAE and BERA in populations with  the 
following risk factors- prematurity , low birth weight, neonatal jaundice and birth 
asphyxia. 
MATERIALS AND METHODS: 
The Study was designed as a cross-sectional study . A total of 144 high risk 
neonates admitted in newborn departments of Institute of Child Health and 
Institute of Obstetrics and Gynaecology during the period March 2015 to 
September 2015 were studied. High risk status was defined by JointCommittee of 
Infant Hearing criteria (JCIH 2007). 
 RESULT : 
26 Cases were referred by OAE. 6 cases were identified with hearing loss by 
BERA done at 90dB and 40 dB. Referral rate was 18.1% with OAE and 4.2% with 
BERA. Sensitivity of OAE as 16.7 % and the specificity was 81.9 %. Positive 
likelihood ratio with OAE was .923. One case with sepsis had hearing loss 
identified with OAE but it passed BERA in both ears.One case with history of  
ototoxic drug administration had the result  REFER with OAE. But it passed 
BERA in both ears. 
CONCLUSION: 
OAE had higher referral rate and higher number of false positives. BERA is 
therefore considered gold standard in hearing screening.Mean duration of NICU 
stay had a positive correlation with hearing loss. 
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INTRODUCTION 
Early detection of hearing impairment is crucial for normal social 
and emotional development[1]. Prevalence of deafness estimated by 
various studies in newborn is 1.6 per 1000. Prevalence of hearing 
impairment identified by neonatal hearing screening programmes across 
the world were: 1.6/1000 of at-risk infants (India, bilateral)  
approximately 1/1000 (Brazil,); 1–3/1000 (China,) 1.6/1000 (Germany, 
bilateral) and 0.7/1000 (Germany, unilateral); 1.05/1000 (United States, 
Colorado, bilateral) and 0.45/1000 (USA, Colorado, state unilateral); 
1.83/1000 (United States, State of Washington); and 3/1000  in 
(Philippines).[2] 
When hearing loss is defined as loss of  > 25 dB, the prevalence of 
Permanent Congenital Hearing Loss (PCHL)  reaches 3 babies per 1000. 
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Universal Neonatal Hearing Screening (UNHS) is followed in 
developed countries for the early detection of hearing loss. It involves the 
use of objective testing methodologies (usually oto acoustic 
emission (OAE) testing or automated auditory brainstem 
response (AABR) testing) to screen the hearing of the whole population 
of newborn in a particular target region.[4] 
 
Targeted neonatal hearing screening is selective hearing screening in 
which only a specific population within a region are screened (NICU 
neonates or patients coming under JCIH criteria). 
 
Present scenario : 
OAE is used as a screening tool in most countries while AABR is 
coming into vogue in developed countries as primary screening tool. In 
India and China, TEOAE and DPOAE are the primary tools in first and  
second stage. In USA, TEOAE is used as a screening tool, while AABR 
is used in second stage. In Germany, AABR is used as the primary 
screening tool. In India both the levels are conducted in tertiary care 
hospitals as audiological facilities in primary care level are still primitive. 
In European nations, second stage is usually done at specialist audiologic 
centres. 
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US Preventive Services Task Force(USPSTF) in 1999 concluded 
that current evidence neither suggested implementation of  universal 
hearing screening nor against  .However the same organisation declared a 
landmark statement supporting the establishment of nationwide screening 
programs. The 1993 National Institute of Health (NIH) Consensus 
Statement and the 1998 European-Consensus Statement on Neonatal 
Hearing Screening are the other relevant consensus regarding policies 
governing hearing screening program. 
 
Policy regarding Hearing screening  in India is still in evolution. 
Prevalence of  Hearing loss  in NICU setting[3] is nearly 1% indicating 
urgent need for proper hearing screening programs. 
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Etiological factors for hearing loss. 
Non-genetic causes (33.30 %) : 
 Jaundice  
 Embryopathies 
 Toxaemia of pregnancy 
 First trimester bleeding 
          Infection 
 Ototoxic drugs 
 Rh incompatibility 
Perinatal causes (10.8%) : 
 Birth asphyxia 
 LBW (<2.5 kg) or prematurity 
 Malpresentation 
Post-term 
Post-natal causes (12.5%) 
 Eruptive fevers 
 Meningitis 
 Hyperbilirubinemia 
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 Traumatic 
 Cerebral palsy 
Genetic causes  
Congenital syndromes (5.4%) 
Idiopathic (50.6%) [5] 
 
Types of Hearing Loss : 
Conductive hearing loss : 
It is defined as hearing loss which occurs due to anatomic 
obstruction or atresia of outer canal  or middle ear. 
Sensorineural hearing loss : 
It is defined as hearing loss which occurs due to pathology 
involving the eighth nerve or the inner and outer hair cells of the cochlea . 
Auditory dyssynchrony : 
It occurs due to pathology of the myelinated eighth nerve fibres or 
inner hair cells causing impairment in transmission of impulse. 
Mixed hearing loss : 
Combination of transient or permanent conductive hearing loss 
with sensorineural hearing loss .[6] 
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Transient conductive hearing loss : 
It occurs due to accumulation of debris in the auditory canal. 
Pre-lingual Hearing loss 
It occurs when the onset of hearing loss manifests in early infancy 
causing impairment of the communicative ability of the child. 
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CONGENITAL HEARING LOSS : 
Nearly 50 % cases with pre lingual deafness are due to genetic 
causes. There about 100 loci identified for genes coding proteins required 
for functioning of cilia, spiral ganglion and other components of the hair 
cell. Dysfunctional proteins have been identified in calcium- potassium 
homeostasis, stereo -cilia linkage, apoptotic signalling and mechano-
electric transduction. 
Genetic hearing loss could be syndromic (30 %) or non-syndromic 
(70%). There are about 350 syndromes associated with hearing 
impairment; one of the common causes of non-syndromic and genetic 
cause of deafness is connexin-26 mutation which is autosomal recessively 
inherited. Skin manifestations can occur with Connexin mutants resulting 
in a syndromic association keratitis ichthyosis deafness (KID) 
syndrome and palmo-plantar keratoderma with deafness 
Mode of transmission of genetic causes is autosomal dominant in 
22 % of cases  , autosomal recessive in 75 % and X-linked in 3 %.[7] 
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Cochlear anomalies : 
In cochlear anomalies, the severity varies depending on the exact 
time at which an insult occurs during embryogenesis and may have 
different manifestations. 
Jackler Classification is used to classify cochlear dysplasias. It 
depend on the gestational age at which development of cochlea gets 
arrested.  
Cochlear dysplasias can occur due to insults occurring at any point 
of time between third and seventh week. 
1. Third week -Labyrinthine aplasia- complete (also known as 
Michel’s deformity) 
2. Fourth week - Cochlear aplasia 
3. Fifth week - Common cavity to the cochlea and vestibule  
 and cystic cochleovestibular anomaly (incomplete partition IP)  
 type I  
4. Seventh week- Mondini’s dysplasia; Incomplete partition (IP)  
type II . [8] 
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AUDITORY DYSSYNCHRONY (AD) : 
It could be congenital or acquired.  While in other causes of SNHL, 
both OAE and BERA responses are abnormal, AD is unique in the sense 
that, while ABR is abnormal, OAE response is normal . 
This indicates that outer hair cell functioning is normal while 
auditory nerve dysfunction exists. The site of lesion for AD include  
cochlear spiral ganglia, cochlear inner hair cells and the auditory nerve. 
Audiograms of children with AD vary from hearing in the normal range 
with difficulty in  hearing in noisy background  to profound hearing 
loss.[9] 
 
Risk factors for AD : 
1. Neonatal jaundice (> 20 mg/dL) 
2. Birth asphyxia 
3. Infections 
4. Family history  
5. Congenital neurological problems 
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GRADING OF HEARING LOSS : 
Hearing threshold 
Normal hearing sensitivity       ≤25 dB 
Mild hearing loss                   30-45 dB 
Moderate hearing loss           50-65 dB 
Severe hearing loss                70-85 dB 
Profound hearing loss           90 dB and above. 
Mild hearing impairment with 30 db is significant enough to impair 
normal communication. Profound hearing loss with hearing impairment 
in excess of 90 db are candidates for cochlear implant program.[10] 
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Physiology of hearing : 
Phenomenon of hearing is a complex process. Sound energy 
transmitted as vibrations through air, strike on the tympanic membrane. 
Vibrations are transmitted through 3 auditory ossicles to oval window. 
Mechanical vibrations induce motion in cochlear fluid, thereby 
transmitting the intensity and frequency of vibrations. Sound vibrations 
causes scala vestibuli to displace inward, simultaneously causing outward 
displacement of scala tympani which is otherwise called the round 
window reflex.  
Vibratory motion generates nerve impulse. Cochlear epithelium is 
composed of hair cells - about 16,800 in each  ear. Hair cells those 
respond to frequencies above 2000Hz are located in basal turn of cochlea. 
Others are in middle and apex of cochlea.  
Peripheral neurons of cochlea are distributed to hair cells beneath 
the basilar membrane. Each outer hair cell is innervated by many 
neutrons while each inner hair cell, by a single neuron.[11] 
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Auditory Pathway : 
Cochlear nerve fibres which originates from spiral ganglion 
terminate in dorsal and ventral cochlear nuclei. Then the fibres decussate 
resulting in bilateral representation. 
Auditory fibres ascend along the lateral lemniscus, reach the 
brachium of caudate colliculus synapsing with  the medial geniculate 
body. From there, axons reach the primary auditory cortex seen around 
the sylvan fissure via the internal capsule.Decussation occurs across the 
trapezoid body.  
Synaptic connections occur with dorsal trapezoid nucleus , nucleus 
of lateral lemniscus and nucleus present in caudate colliculus.[12] 
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Otoacoustic emission : 
An otoacoustic-emission (OAE) is a inaudible sound that is 
produced  from the inner-ear . It arises in the external auditory canal 
when the tympanic membrane receives vibrations transmitted in a 
retrograde manner, through the middle ear from the inner ear. When the 
inner ear gets affected, OAEs are not produced; hence it assumes clinical 
importance. 
 
Mechanism 
Cochlea acts as a amplifier and this function serves as the basis of 
OAE production.In the absence of external stimuli, this function is higher 
resulting production of acoustic emissions. 
OAE is recorded via ear canal probe that is  inserted into the ear 
canal. Click stimuli of a 80 dB level can evoke a robust Transient Evoked 
OAE response only if hearing threshold is more than 20 dB. 
Normal emissions that are recorded in neonates are about 15-30 db 
range. Signal processing is not required to assess this output from noise 
and fully validated frequency-specific recordings can often be made in a 
few seconds. BERA requires a much complex process with electrodes so 
as to distinguish from background EEG out output. 
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2 types of OAEs include spontaneous oto-acoustic emissions 
(SOAEs), that does not require stimuli, and transient evoked oto-acoustic 
emissions (TEOAEs), that requires an stimulus to evoke emissions. 
 
Types of OAEs 
Spontaneous OAEs 
Spontaneous otoacoustic emissions (SOAE)s are inaudible sounds 
that are produced without any evoking stimulus and are measurable with 
sensitive probes in the external ear canal. The sounds are frequency-
stable between 500 Hz and 4500 Hz. The majority of the people do not 
hear  their SOAEs; Some people (about 1-9%) however perceive a SOAE 
as  tinnitus. 
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Evoked OAEs 
Evoked otoacoustic emissions are currently evoked using three 
different methodologies. 
 1.Stimulus Frequency OAEs (SFOAEs) are assessed after 
application of pure tone stimulus. 
 2.Transient-evoked OAEs (TEOAEs ) are evoked using a 
stimulus which could be tone or click evoked . Click response occurs due 
to a frequency of around 4 kHz, while tone burst  occurs due to a single 
pure tone frequency.  
 3.Distortion product OAEs (DPOAEs) are elicited with 2 primary 
tones. Non-linear intermodulation occurs with both of the tones within 
cochlea generating new components of frequency, which can travel to the 
ear canal. Healthy ear canal distortion levels can be above 20 dB SPL. 
 
Sensory transmissive loss occurs due to outer hair cell 
malfunction. Absence of the ‘amplifying function’ of cochlear apparatus 
allows dampening to remove most stimulus energy from the cochlear 
travelling wave and lowers the resolution of the cochlear imaging 
mechanism. 
Sensory transduction loss occurs due to inner hair cell 
malfunction in activating the nerve fibres. 
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Clinical importance 
OAEs are highly useful in newborn screening as they are easy to 
do in non-co-operative patients and the methodology is simple. 
Method : 
 In OAE a  probe is kept in the external auditory canal of the 
newborn. There should be  no debris or mechanical obstruction blocking 
the ear canal. This commonly happens in < 48 hours due to vernix 
deposition. If the result is “refer” and mechanical block is suspected , the 
babies are re-examined after 2 days anticipating spontaneous resolution 
of debris. [13] 
 
Brainstem evoked response audiometry: 
Definition :  
Brainstem evoked response audiometry (BERA) is done using 
audiological click stimuli eliciting brain stem potentials resulting in 
production of waves that are then recorded using scalp electrodes.. This 
method of hearing evaluation was first introduced by Jewett and Williston 
in the year 1971. 
Procedure:  
The stimulus either in the form of click or tone  is transmitted to 
the ear via a transducer placed in a head phone. The wave forms of 
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impulses generated at the level of brain stem are recorded by the 
placement of electrodes over the scalp. 
Electrode placement:  
The conducting electrodes are kept over scalp. Care must be 
ensured that the surface of scalp is dry without oil. As per the routine 
configuration of ABR electrodes , one of them is kept on vertex  and 
inverting electrodes placed over the ear lobe of the ear which is assessed 
or the mastoid prominence. Another  electrode is kept on forehead for the 
purpose of earthing. This earthing electrode is necessary for proper 
functioning of the  pre-amplifier.  
After ensuring the baby is sleeping or is in quiet alert state, click 
stimulus is applied. We use 40 db and 70 db for screening.  Impedance 
matching is done  prior to the procedure.  
After observing for  the appearance of typical wave pattern , 
average sum of potential evoked is noted. The process is repeated with 
opposite ear.  
1. Eighth nerves - waves I and II 
2. Cochlear nucleii - wave III 
3. Superior-olivary complex - wave IV 
4. Nuclei of lateral lemniscus - wave V 
5. Inferior colliculus - waves VI and II[14] 
 
18 
 
Wave v is the largest in size and the most easily identifiable wave 
in recording as sharp negative deflection  
Equipment : RMS BERA MARK 2 machine was used 
INTERPRETATION : 
While interpreting BERA waves, amplitude , latency and interwave 
latency is noted. Amplitude measures the number of firing neurones , 
latency - the processing speed and interwave latency measures the time 
between peaks. 
From 70 dB intensity recordings are made and the intensity is 
lowered. Wave V is noted with each lower intensity and the minimum at 
which it occurs is defined as hearing threshold 
 
Finding suggestive of pathology : 
1. Absent brain-stem response 
2. Absolute inter-aural fifth wave latency 
3. Wave I to V interpeak latency 
 
Delayed and absent waves : 
BERA waves represent a summated activity of large populations of 
neurones firing in synchrony. Delayed waves occur if there is uniform 
delay in neutron firing. 
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Absent waves occur when the delay is non uniform due to temporal 
dispersion. 
LATENCY : 
Wave I : 1.5 seconds 
Wave III : 3.57 seconds  
Wave V : 5.53 seconds[15] 
 
PROCEDURE : 
1. 10 - 20 system is the standard that is used world-wide for placing 
electrodes. 
2. Standardised silver and silver chloride electrodes are commonly 
used. 
3. Frequency of click is 10/ second 
4. A masking sound of about 40 dB is applied on the contralateral ear. 
5. About 2000 to 4000 responses of electrical activity is noted. In 
newborn usually 2000 responses are used and its average sum is 
noted. 
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Behaviour response audiometry : 
It involves presenting sounds and observing their responses.  
Usually overt responses to controlled auditory stimuli are assessed. It is 
commonly used in 6 - 9 month age group. It is done using standardised 
bell, rattle or noise- making toy.  
It is useful in following settings. 
1. In neurologically immature babies where ABR cannot be reliable. 
2. To provide information about low frequency hearing loss. 
3. To demonstrate the benefit of hearing aids.[16] 
 
NICU SCREENING PROTOCOL (NNF Guidelines) : 
 NICU 
a) AABR is  the hearing screening method of choice for all NICU in-
fants; OAE in settings where AABR is unavailable. 
b) Initial screen: Each ear is attempted twice to collect valid recording 
c) Second screen: Should be done in subsequent day. Such attempts 
can be made upto 2 times 
d) Maximum: Avoid doing hearing screening more than twice 
e) Any neonate needing more than 5 days of NICU care must be 
screened with ABR, so as not to miss sensorineural loss. 
f) ABR failures require confirmatory BERA testing.[17] 
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COCHLEAR IMPLANT PROGRAM - INDICATION 
Cochlear implant devices can be used for children of 12 months 
and older. 
CI evaluation of a in infant age group should include the following:  
Behavioural audiometry (i.e., Visual Reinforcement Audiometry),  
OAEs,  
 ABR  
ASSR, Auditory steady state response 
Tympanometry, and 
Acoustic reflexes.  
Positive OAEs with absent ABR or ASSR and absent reflexes 
should generate suspicion of AN/AD.[18] 
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JOINT COMMITTEE ON INFANT HEARING : 
High risk criteria of newborn was devised by JCIH, an Association 
with representatives from American Academy of Pediatric, American 
Speech Language Hearing Association and American Academy of 
Ophthalmology and Otolaryngology . 
It propagates EHDI- Early Hearing Detection and intervention 
program with emphasis on 3 points 
1.Early detection - soon after birth 
2.Follow up screening 
3.Early intervention 
Golden rule of hearing screening is 1-3-6. 
1.Universal screening of all newborn by one month  
2.Confirmatory testing by ABR for all screened positive 
3.Early intervention by 6 months 
Reach of hearing screening has improved greatly in developing 
countries with coverage reaching upto 92 %.[19] 
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NATIONAL PROGRAMS 
1.NATIONAL PROGRAMME FOR PREVENTION AND 
CONTROL OF DEAFNESS : 
Early identification, diagnosis and treatment of ear problems 
responsible for hearing loss and deafness is one of the important 
components of this program.Rehabilitation of deaf children is included in 
this program. It mainly focuses on training of ENT surgeons and 
audiologists at primary and secondary care level. Sensitisation of 
Paediatricians regarding early screening is done by means of training 
modules.[20] 
 
Rashtriya Bal Swasthya Karyakram (RBSK) is an healthcare 
initiative aiming at early intervention for children from birth to 18 years 
to cover 4 ‘D’s which includes  Defects at birth,Diseases, Development 
delays including disability.Deafness is included under the 30 ailments 
covered in this study.Early intervention centers are to be established at 
the District Hospital level across the country as District Early 
Intervention Centers (DEIC). The purpose of DEIC is to provide referral 
support to children detected with health conditions during health 
screening, primarily for children up to 6 years of age group. 
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REVIEW OF LITERATURE 
The relevant studies done in the area of hearing screening in both 
India and other countries are listed below. 
 A descriptive study was done in the year 2014 in ENT department, 
CMC Vellore by Achamma Balraj et al in which 9448 babies 
were screened and  followed up. Period of this study was 11 
months. 164 had suspected hearing loss and on subsequent follow 
up, 39 had deafness 
 Using BERAphone, a portable BERA equipment, 2 stage screening 
process was done. Newborn babies suspected to have hearing loss 
then underwent confirmatory testing using  ASSR auditory steady 
state response audiometry. In addition, serological testing for 
TORCH infections (6 were tested positive), and connexin gene     
(1 proved positive) mutation was done. Neonatal hearing screening 
using BERA was identified to be a feasible service. The estimated 
prevalence of confirmed hearing loss (1.4) was comparable to that 
in literature (1.6). 
 Comparative evaluation of BERA and TEOAE as screening 
modality for hearing impairment in neonates was done by  Mathur 
et al in Lady Hardinge Medical college in the year 2007. The study 
group of 200 randomly selected neonates was subjected to TEOAE 
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and BERA (400 ears). In all TEOAE failures oto-endoscopic 
cleaning was done to remove debris (52) and a repeat test was done 
after suction cleaning of blocked external auditory canal (EAC). 
Pass rate was 92 %. In <48 hr age group, it was 55 % suggesting 
high prevalence of obstructed ear canal. 
 Feasibility of a 2 stage hearing program was first assessed by Vaid 
et al. A neonatal hearing screening programme has been 
established in Pune, India. From August 2005 to August 2007 a 
total of 2621 babies were tested using otoacoustic emissions 
(OAE), followed by second stage brainstem evoked response 
audiometry (BERA) for those who  were referred on the second 
OAE testing. 
249 were referred on the second OAE testing and of these, only fifty 
two came back and were further evaluated using BERA. 15 of these fifty 
two babies were found to have a significant hearing loss.  
 Comparison of distortion product otoacoustic emissions and 
automated auditory brainstem response in the same ear of the 
babies in neonatal unit was studied by Wahid et al. AABR has a 
higher passing rate as compared to DPOAE. However, the use of 
both instruments in the screening process especially in NICU will 
be useful to determine the infants with ANSD who may need 
different approach to management. Therefore, a protocol in which 
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newborns are tested with AABR first and then followed by 
DPOAE on those who fail the AABR is recommended. 
 TEOAE was compared with BERA by Granell in terms of 
accuracy, duration of testing with the results favouring BERA in 
terms of pass percentage. 860 newborns were screened with OAE 
and 2300 were done with evoked response audiometry. Median 
time for performing BERA was 265 seconds.  
 2 stage hearing program in Indian population was studied by 
Bansal et al - OAE at 48 hours after birth and those cases which 
failed was screened with BERA. 2659 babies were screened. Pass 
percentage was 77.5 percent.  
 A number of studies were done on high risk cohort. Hess et al  did 
a study on high risk screening done with BERA and TEOAE. 942 
neonates were screened and 835 passed. The prevalence of 
deafness came out to be 1.4 %. 
 Deafness in German population was analysed by Ohi et al. JCIH 
criteria was used to identify high risk population and both BERA 
and OAE was used. Conductive deafness was noted  in many cases 
with craniofacial anamolies. 1455 babies were screened and hard 
of hearing was detected in 4.55 % of cases. 60 cases were 
identified with deafness. 
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 2 stage AABR testing was analysed by Van s’raaten et al . More 
than two thousand babies were screened and referral rate was 
identified to be 3 %. This prospective study collected data on 2513 
neonates who were discharged from NICU. NICU graduates with 
JCIH risk factors were included in a 2 stage AABR hearing 
screening programme. Conventional ABR was used to establish a 
diagnosis of CHL. 
 A total of  2513 newborns were  enrolled in the programme with a 
median gestational age of 31.6, a median birthweight of 1450 (range 510-
4820) g. In 25 cases, parents refused screening. 4 out of 2513 newborns 
were lost to follow up; 2484 newborns have been tested initially. A  
participation rate was 98 percent (2465/2513) was obtained for the whole 
screening programme.  
 After a median postmenstrual age at the first test of thirty three 
weeks, a pass rate of 2284/2484 (92%) was arrived at the first stage. The 
rescreening compliance after the first test was about 92% 
(184/200).Among those cases, 77 babies were referred for BERA.Of the 
77 referrals, fourteen had normal screening thresholds, fifteen (19.5%) 
had unilateral conductive hearing loss and 48 (62.3%) had bilateral 
conductive hearing loss. The prevalence of unilateral conductive hearing 
loss was 0.6% (15/2484) and of bilateral conductive hearing loss was 
1.9% (48/2484) 
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 Yoshinaga et al studied the benefits of early screening. 46 children 
with early identification of hearing impairment were compared 
with 69 diagnosed late. 23 children in the first group showed  
significant improvement in language abilities while in the 13-18 
month period. When the same cohort was followed up between 19-
24 months, 28 children showed significant improvement. 
 University of Washington research is one of the largest program 
till date. Nearly 7000 babies were  screened with TEOAE, DPOAE 
and ABR. ABR had lower referral rate. 
 Rhode Island Hearing Assessment Program was one of the 
earliest analysis of a state-wide hearing screening program. 11 
babies with congenital hearing loss were detected. Prevalence of 
deafness was 2 %. Mean age of identification of hearing loss was 
3.5 months. 8 maternity hospitals had enrolled in this 4 year 
project. 
 In BJMC, Ahmedabad Amitkumar et al did a similar study 
comparing AABR and OAE.TEOAE referred patients were further 
screened by Automated AABR. About 284 patients passed OAE 
and 11 babies were identified with hearing loss. Low birth weight, 
hypoxia , jaundice were identified as risk factors. 
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 As a pilot study C.S Gohill et all studied 3 stage hearing protocol. 
300 babies were screened with OAE. 24 babies were referred for 
2nd OAE. 18 babies were detected who were then referred for 
subsequent BERA examination. 12 failed BERA test. Incidence of 
hearing loss was 8 % as per this study. While OAE is accepted as a 
low cost screening tool, BERA was identified as the gold standard 
for hearing loss. 
 
 Incidence of deafness in Chinese was assessed by Xu et al who 
performed 2 stage hearing study in Shangai NICU 
population.Three thousand high-risk neonates were screened at 
Children's Hospital in Fudan University. They were randomised 
and then directed to two different screening procedures separately.  
 
The first procedure consisted of DP-OAE alone and the second 
consisted of first stage DPOAE combined with the AABR. The combined 
DPOAE plus AABR screening technique showed a total referral rate of 
5.03%, a false-positive rate of two percent and a total false-negative rate 
of about 0.06%. Comparisons of the referral rate, false-positive rate , 
sensitivity and false-negative rate of the two hearing screening program 
protocols (DPOAE alone and combined DPOAE/AABR) revealed 
significant differences .  
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Ninety one infants (3.03% of the NICU graduates) who failed the 
combined DPOAE plus AABR screening were confirmed to have hearing 
impairment. Of  the  twenty, two  babies who passed DPOAE screening 
but failed to clear the AABR screening had a profound hearing loss based 
on classic brainstem response audiometry. 
 
 Meier et al compared ease of use and accuracy of multiple 
equipements. OAE, the Fischer-Zoth’s Echoscreen-TDA, and two 
AABR screening equipments, the Algo 3 and the MAICO’s 
Beraphone MB11, were tested prospectively.Transiently-evoked 
oto-acoustic emissions (TEOAE) and also distortion-product 
otoacoustic emissions (DPOAE) were assessed in both ears of 
hundred and fifty newborns from nursery using the Echoscreen-
TDA. 150 babies were split into 3 equal groups and assessed with  
each of the above said equipment. 
Tests were done on day 3 of life. The median test duration in one 
ear was thirty seconds for EOAE measurements and four to five min for 
AABR recordings. Expense for the disposables and machine were least 
for the Echoscreen and MAICO’s Beraphone MB11, respectively and 
maximum for the Algo 3. 
With ninety eight%  the rate of passing was maximum for AABR 
recordings using the Algo 3 and least with ninety two percent for 
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Automated ABR recordings using the MB11-Beraphone, but differences 
were statistically insignificant. 
 7 hospitals were involved in a multi centric study by Johnson et al 
which were already following 2 stage hearing screening protocol 
with OAE and AABR were enrolled. More than eighty thousand 
neonates were involved in this study.  
Those babies with OAE-refer but have cleared automated-ABR in 
atlas one ear 1524 were enrolled in the study. Details about risk factors of 
hearing loss were assessed in these babies.In about 64 % of participants 
study was done after 8 months of age. 
There was SNHL in 21 infants who passed automated ABR but 
failed in OAE. 23 (seventy seven percent) of the ears had mild hearing 
loss (average of 1 kiloHz, 2 kiloHz, and 4 kiloHz < or =40-db hearing 
level). 9 (43%) infants had bilateral as opposed to unilateral loss, and 
eighteen (86%) infants had sensorineural hearing loss as opposed to 
conductive hearing loss. 
If all participants were screened for hearing impairment using the 
2-stage OAE/A-ABR newborn hearing screening protocol currently used 
in many hospitals, then approximately 23% of those with permanent 
hearing loss at approximately 9 months of age would have passed the A-
ABR. The study also shows the importance for continued follow up of 
hearing status during childhood. 
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 University of Bordeaux did a study in determining the correlation 
between brainstem response BERA and behaviour response 
audiometry BOA . There was no behavioural audiometry response 
at hundred dB when there was no brainstem response at 100 db, in 
84.2% of cases, thus resulting  in a k coefficient of 0.72.  
 
The difference between the ABR and the BA thresholds, when there 
were response with BERA was equal to or less than ten dB in 67% of 
cases and equal to or less than twenty dB in 95% of cases. (2) 
Longitudinal study (fifty children). Hearing threshold determined via 
behaviour observation audiometry was similar (within a difference of less 
than 10 db) when compared between 4 to 18motnh period and 3 to 4 
years at the frequencies of 1000, 2000 and 4000 Hz and in 78% of cases 
at 500 Hz. 
Both of these analysis provide evidence to  the validity of the 
behavioral audiometry measurements  at an early age using the above 
mentioned protocol.  
 Ulusoy et al  studied a total 11575 neonates that were either born 
in Çorlu State Hospital, located in Turkey, between September 
2009 and November 2012 were included into the study. Automated 
TEOAE Transient Evoked Otoacoustic Emission test and 
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AutomatedAuditory Brainstem Response (AABR) were used as 
screening procedures.  
 
TEOAE is the initial screening test. Failures are repeated after 15 
days. Subsequent testing are done with ABR at ENT centres.Nearly 600 
babies failed among the fifteen thousand neonates who took the test (5.12 
%). Those neonates were referred for ABR. Out of these 593 neonates, 
four hundred and seventy had passed the diagnostic ABR test at the 
referral center. Unilateral & bilateral sensorineural hearing impairment 
(SNHL) was detected at fifteen & seven babies 
respectively;Consanguinity and family history of hearing loss were some 
of the risk factors present in the 22 babies screened positive. 
 In Indian population, Mishra et al estimated the prevalence of 
deafness in < 2 age years as 1 %. 1101 infants were screened and 
126 were suspected to have hearing loss. High risk group among 
this population was 50 %. 12 children were identified with 
deafness. It was found out that positive predictive value of OAE 
increased with multiple tests.  
 Dhingra et al compared Behaviour response audiometry(BOA) 
with AABR and OAE and Auditory steady state response ASSR. 
BERA was taken as reference Sensitivity of AABR and BOA was 
nearly the same (94%). OAE had higher sensitivity (97%). But 
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OAE had much lower specificity 59%. Cost analysis was done.     
BERA (Rs 200/ test) was more expensive than OAE(Rs 40) and 
AABR(Rs 40) despite re-using scalp electrodes. BERA equipment 
(14 lakhs ) was more expensive than OAE (2.5 lakhs). BERA, 
AABR and ASSR was done using the same equipment. Cost 
included disposables, cotton, conducting gel etc. 
 Influence of prematurity as a risk factor was studied by Kilic et al 
in Turkey. 
29 premature babies were screened with BERA and were compared 
with 29 Term babies in the control group.  
While the study failed to prove prematurity as a risk factor , 
mode of delivery, low APGAR score and neonatal jaundice were 
recognised by this study. 
 Safety of Cochlear implant program in infants less than 12 months 
was studied by O’connell et al. The study showed the difference in 
post operative complications in less than 12 month age group and 
12 to 18 month age group was statistically insignificant paving the 
way for early interventions .This makes early identification 
programs crucial for identifying candidates for early surgery. 
 Impact of early identification programs was evident by study done 
by Lammers et al .  Mean age of identification came down from 
2.4 years to 1.2 years. Percentage of early implanted babies 
35 
 
increased from 9 % to 37 %. Thus indicationg that hearing 
screening programs have a major influence in improving the mean 
age of hearing implanted infants. 
 A series of studies done by Gordon of et al revealed re-
organisation of auditory cortex by cochlear implant. Early 
intervention facilitates auditory development in thalamo-cortex . 
 Referral rates as well as prevalence of deafness in newborn 
population was done in Chennai by Jaya et al. Thousand and four 
hundred babies were screened by OAE .Using ABR second stage 
screening was done.  
Three hundred and eleven babies were referred by first stage. 31 
babies were referred for subsequently for further testing. Ultimately two 
babies were identified with profound hearing loss. Both high risk and 
newborn population was studied in this landmark study. 
 Bera changes specific to hyperbilirubinemia were studied. Loss of 
peaks, latency of third and fifth wave and elevated hearing 
threshold were noted by V.K AGARWAL et al .  
These findings were reversible when BERA was done after 6 
months indicating some of the insults due to bilirubin encephalopathy 
were transient. This also highlights the need for serial testing and multi-
staging of hearing screening protocol rather than a single stage program. 
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 Auditory neuropathy spectrum disorder was identified as discrete 
entity by Kaga et al . Three distinct subclasses were found.  
Normalisation of hearing occurred in first type .Second type 
developed profound hearing loss. Third type resembled auditory 
neuropathy of the adult hence termed true auditory neuropathy.  
 Prognosis of cochlear impants in these cases were studied by 
Breneman et al and were found to have similar success rates as 
that of other children with sensorineural hearing loss. They showed 
poor response to hearing aids. 
 Mutations in Connexin twenty six and thirty were identified as 
cause of hearing loss in population with SNHL in Sicily . Sixty 
eight out of One hundred and ninety six patients were found to 
have this genetic mutation.  
This proves that genetic mutations is a common cause of non-
syndromic hearing loss and connexin mutations contribute to large part of 
this genetic cause 
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STUDY JUSTIFICATION 
Importance of screening for major diseases in newborn is on the 
rising trend.As mentioned earlier, in February 2013, Rashtriya Bal 
Swasthya Karyakram (RBSK), a new initiative aimed at screening over 
27 crore children was launched. Since deafness is included under this, 
early identification of hearing loss is need of the hour. Children thus 
diagnosed with illnesses shall receive follow up including surgeries at 
tertiary level, free of cost under National Rural Health Mission (NRHM). 
Early screening will supplement cases to this program. 
Optimisation of hearing screening protocols is essential. While 
OAE remains the ideal tool in low resource settings, BERA screening is 
needed to rule out auditory nerve dysfunction. OAE  has a higher referral 
rate due to higher false positive results. This leads to parental anxiety and 
need for multiple visits to tertiary care centre.  
BERA screening is limited by its expense, need for trained 
audiologist for testing and validation. Noise free environment with 
insulation from electrical disturbances and proper power connections are 
necessary for obtaining a valid result.  
Though a number of studies have been done in other countries 
regarding hearing screening protocols, data regarding Indian population 
with regards to high risk screening is lacking.  
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This study has been envisioned to bridge that gap and to add data 
to our existing pool of resources, to make an informed decision regarding 
choice of hearing screening tool, protocol and the man power. 
Burden of Hearing impairment is expected to rise due to increase in 
number of preterm babies and babies who have received intensive care. 
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AIMS AND OBJECTIVES 
AIM : 
 To compare the diagnostic ability of Oto-acoustic Emission and 
brainstem evoked response audiometry in hearing screening of high risk 
infants. 
OBJECTIVE : 
1. To determine the ideal hearing screening tool in high risk newborn. 
2. To study the referral rate of OAE and BERA in populations with  
the following risk factors- prematurity, low birth weight, neonatal 
jaundice and birth asphyxia. 
3. To reduce false positive rate of OAE by 2-stage hearing program. 
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HYPOTHESIS 
 
Null hypothesis assumed in this study include 
1. There is no difference in diagnostic ability of OAE and BERA. 
2. There is no correlation between parameters like  age, sex, neonatal 
jaundice, sepsis, birth asphyxia, ototoxic drugs  and  Hearing loss 
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SUBJECTS AND METHODS 
Study Design  : Cross-sectional study   
Place of study  : Newborn department, ICH and IOG 
Period of study  : March 2015 to September 2015 
Study population  : High risk newborn (JCIH criteria) 
Sample size   : 144 based on prevalence in high risk  
infants 
 
Approval was obtained from Institute ethical committee.  Written 
consent was obtained from parents in a pre- structured proforma, prior to 
the procedure. 
 
Equipment : 
BERA : RMS BERA mark 2 machine was used.  
OAE  : Neurosoft machine (TEOAE) was used. 
Disposables : Scalp electrodes, cotton, conducting gel. 
 
Inclusion criteria : 
High risk neonatal population as defined by JCIH criteria. 
Risk factors that are seen with hearing impairment 
(JCIH risk criteria of 2007)  
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 Concern from family members regarding hearing loss 
 Positive Family-history of hearing impairment  
 Neonates requiring NICU care > 5 days,  including administration 
of   
o Ototoxic medications 
o Assisted ventilation 
o Hyperbilirubinemia requiring exchange transfusion  
 Postnatal infections  (meningitis, sepsis) 
 In utero infections, including TORCH- CMV, herpes virus, rubella, 
syphilis, and toxoplasmosis  
 anomalies of the pinna or ear canal,cleft palate or lip ear tags, ear 
pits, or temporal bone anomalies and other craniofacial anomalies. 
Syndromic causes of hearing loss   
 Neuro-fibromatosis 
 Osteopetrosis  
 Waardenburg syndrome 
 Alport syndrome 
 Jervell syndrome 
 Lange-Nielsen syndrome 
 Pendred syndrome 
 Usher syndrome 
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 Treacher-Collins syndrome  
All high risk babies discharged during study period were included 
in the study.  
Parents or grand-parents of the babies were informed about the 
study and consent was obtained. 
Details of the baby including name, gestational age, sex, birth 
weight, address and contact number were noted. Significant antenatal  
history and course of NICU stay including treatment details of birth          
asphyxia, Neonatal jaundice and ototoxic drugs used. Family history of 
hearing loss was probed. 
DEFINITIONS 
LOW BIRTH WEIGHT (LBW) 
Birth-weight <2500 gm 
VERY LOW BIRTH WEIGHT (VLBW) 
Birth-weight < 1500 gm  
PRETERM 
Gestational age of less than two hundred and fifty nine days or thir-
ty seven weeks 
TERM 
Gestational age of Two hundred and fifty nine to two hundred and 
ninety three days or thirty seven completed weeks to forty two completed 
weeks 37 to less than 42 completed weeks. 
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Neonatal hyperbilirubinemia was defined as that requiring exchange 
transfusion or phototherapy more than 5 days. 
Birth asphyxia:  
Apgar score of less than 7 at 1 minute of age  
Family history of hearing loss and maternal concerns about hearing 
loss if any were noted. 
Ototoxic drugs included were amikacin, gentamicin and loop diuretics. 
Hearing loss defined as hearing assessed  by brain-stem response        
audiometry to be less than threshold levels for normal hearing. 
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STUDY MANOEUVER 
A detailed examination was done looking for craniofacial anoma-
lies especially ear anomalies like microtia, pre-auricular tags or pits. 
Family history of hearing loss and maternal concerns about the 
neonates hearing was noted. 
Details were noted in the proforma; the screening results were 
filled in by the  audiologist . OAE result was obtained separately from 
routine screening program and was added to data. 
  OAE was done with complete automated screener which displayed 
the results as either “PASS” or “REFER”.  Parents of babies which failed 
were explained about the prognosis and the need for further testing. 
  BERA was done with RMSTM screener. Waveforms were observed 
and validated by audiologist in real time. Waves were stored in hard disc 
for future reference.  
   OAE was done in 144 babies in IOG by routine  screening by  the 
audiologist .  All babies were referred to ENT department ICH for further 
testing. BERA was performed by trained audiologist hired for this study. 
OAE failures were asked to return for repeat testing to rule out blockage 
of ear canal.  
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Newborn ABR : 
 Room must be noise-free, with plenty  sound absorbing surfaces. 
Proper Earthing of electrical supply is vital. This must be checked 
before establishing the room with electrician. Earthing can be 
ensured by asking the parent to keep her legs on a wooden table. 
 Preparation time of newborn is about 10 minutes. We did the study 
with the baby in quiet alert state soon after being breast fed. Older 
babies can be sedated with Triclofos syrup if needed 
 Since skin of newborn peels easily  one should rub alcohol gently 
before placing electrode. Generic alcohol is commonly used but 
Nuprep is preferred for this purpose. 
 Conducting gel should be applied liberally to the electrode and 
fixed to skin with micropore plaster. Regular white plaster should 
be avoided. 
 Average sum of 2000 electrical responses should be electrode. This 
ensures generation of a  proper waveform.  
 The electrodes should be wiped off the gel and immersed in a cup 
of distilled water to maintain its conducting property 
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Babies who failed in BERA were asked to review after 2 months 
for confirmatory BERA testing. 
2 Contact numbers were obtained from both OAE and BERA refer-
rals. OAE failures were asked to return for repeat OAE testing after 1 
month. 
BERA failures were informed about the prognosis and the need for 
repeat testing at 3 months and the importance of early intervention. Fur-
ther testing was advised at Audiology department at MMC after 2 
months. Details of the cases were given to paediatric ENT department at 
ICH. 
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STATISTICAL ANALYSIS 
The diagnostic ability of hearing loss among the children was     
diagnosed by BERA Vs OAE. The ability of the test was identified and 
inferred by McNemar paired Chi-square test (χ2) test. The diagnostic  
ability was done screening test and interpreted the results by Likelihood      
ratios.  
The factors which are correlated with deafness were interpreted by 
Pearson chi-square (χ2) test. The significance of the measurable           
characteristics like age and NICU admissions were compared between the         
diagnosed subjects by students’  “t” test. The above statistical analysis and   
interpretations were performed by an appropriate statistical package. 
The p- values less than 0.05 were considered as statistically significant 
(P<0.05).       
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RESULTS 
Comparison of predicting percentage 
The three diagnostic tests were analyzed and tabulated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
50 
 
Table-1.Classification of hearing loss in the three diagnostic tests: 
 
Hearing 
Loss 
OAE BERA 90 db BERA 40 db 
Frequency % Frequency % Frequency % 
Nil 118 81.9 138 95.8 138 95.8 
Left   
ear 4 2.8 0 0.0 1 0.7 
Right 
ear 9 6.2 0 0.0 0 0.0 
Both 13 9.1 6 4.2 5 3.5 
Total 
loss (26) (18.1) (6) (4.2) (6) (4.2) 
Total 144 100.0 108 100.0 144 100.0 
 
The total hearing loss predicted by OAE was 26 (18.1%) and the 
other two tests had predicted as 6(4.2%) each.  But BERA 90, predicted 
6 ears of both and the same was considered as Gold standard.  
Among 26 tested positive with OAE, 13 had hearing loss in both 
ears. 13 had unilateral hearing loss with 9 in right ear and 4 in left ear.  
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Table-2. Comparison of predicting positive Percentage of OAE and   
BERA 90: 
OAE 
BERA 90 
χ2paird df Significance 
Yes No Total 
Yes 1 25 26 
12.033 1 P<0.001 No 5 113 118 
Total 6 138 144 
 
 
The percentage of positive prediction by OAE (18.1%) was       
significantly greater than the BERA 90 (4.2%) positive prediction 
(P<0.001). 
 
Diagnostic ability of prediction: 
The predicting capacity of the tests was analysed by screening tests 
with reference to the BERA 90 as Gold standard and OAE diagnostic test. 
The results of the test were interpreted by positive and negative likely 
hood ratio.  
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Table-3: Sensitivity and specificity of the tests: 
OAE 
BERA 90(Gold Std) 
Total 
Positive Negative 
Positive 1 25 26 
Negative 5 113 118 
Total 6 138 144 
 
  
3%
47%
12%
38%
BERA Refer BERA Pass OAE Refer OAE Pass 
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The sensitivity of the test (OAE) was 16.7% and specificity of the 
test was 81.9%. 
Likely hood Ratio + = and Likely hood Ratio - =  
LR+ = .923 and  LR- = 1.02.or 102%. 
The interpretation of LR+ was “ A +ve result on OAE is .923 times 
more likely to occur in a subject with hearing loss as compared to a     
subject who does not have hearing loss”. 
The interpretation of LR- was “ A -ve result on OAE is 1.02 times 
more likely to occur in a subject who really has hearing loss as compared 
to a subject who does not have hearing loss”. 
 At the context of low prevalence rate of hearing loss the above   
interpretations are acceptable and BERA 90 has more diagnostic ability 
than the OAE.  
The age of infants in day and NICU stay were compared between 
positive and negative with respect to BERA-90 db and OAE. 
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Table- 4: Comparison of positive and negative of BERA and OAE of 
infants’ age and NICU stay:  
Test Variable (days) 
Negative Positive Difference 
b/w 
means 
“t” df P 
Mean SD Mean SD 
BERA 
90 db 
Age 16.6 6.0 20.3 9.7 3.7 1.428 106 P>0.05 
NICU 11.3 4.2 15.3 6.6 4.0 2.240 106 P<0.05 
OAE 
Age 16.5 6.0 18.1 7.0 1.6 1.156 106 P>0.05 
NICU 11.3 4.4 12.4 4.4 1.1 1.184 106 P>0.05 
 
In the above table -4 states the positive and negative of subjects 
age and stay at NICU with respect to BERA 90 and OAE. The mean ages 
of Negative and positive of BERA 90 was not statistically significant 
(P>0.05). But the mean duration of NICU stay BERA positive (15.3±6.6 
days) was statistically significantly greater than the negative mean        
duration of 11.1±4.2 days P>0.05). In respect of OAE neither age nor 
NICU stay was  statistically significant (P>0.05) 
. 
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Factors associated with the hearing loss diagnosed by BERA 90 db 
and OAE: 
 The factors like sex, neonatal jaundice, birth asphyxia, ototoxic 
drugs, sepsis, Birth weight and term of the infant were studied to identify 
the association between BERA and OAE. 
 
Association between Hearing loss and sex: 
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Sex 
BERA 90 db OAE 
+ve -ve Total Test value +ve -ve Total 
Test 
value 
Male 2 87 89 χ2=.000 16 73 89 χ2=0.004 
Female 4 51 55 df=1 10 45 55 df=1 
Total 6 138 144 P=1.00 26 118 144 P=0.500 
 
 
Table -5 shows the association between sex and hearing loss 
screened with BERA 90 and OAE. The results revealed that there was no 
significant associated established either positive or negative in both tests 
(P>0.05) 
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Association between hearing loss and NNH: 
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NNH 
BERA 90 db OAE 
+ve -ve Total Test value +ve -ve Total 
Test 
value 
No 5 119 124 χ2=.000 23 101 124 χ2=0.000 
Yes 1 19 20 df=1 3 17 20 df=1 
Total 6 138 144 P=1.00 26 118 144 P=1.00 
 
Table -6 shows the association between Neonatal jaundice and 
BERA 90 and OAE. The results revealed that there was no significant as-
sociated established either positive or negative in both tests (P>0.05).  
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birth as-
phyxia 
BERA 90 db 
OAE 
+ve -ve Total Test value +ve -ve Total 
Test 
value 
No 6 135 141 χ2=.000 26 115 141 χ2=0.000 
YES 0 3 3 df=1 0 3 3 df=1 
Total 6 138 144 P=1.00 26 118 144 P=1.00 
 
Table -7 shows the association between  positive and negative with 
birth asphyxia of BERA 90 and OAE. The results revealed that there was 
no significant associated established either positive or negative in both 
tests (P>0.05).  
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Ototoxic 
drug 
BERA 90 db 
OAE 
+ve -ve Total Test value +ve -ve Total 
Test 
value 
No 6 136 142 χ2=.000 25 117 142 χ2=0.000 
YES 0 2 2 df=1 1 1 2 df=1 
Total 6 138 144 P=1.00 26 118 144 P=1.00 
 
Table -8 shows the association between Ototoxic drugs and hearing 
loss with BERA 90 and OAE. The results revealed that there was no sig-
nificant association, established either positive or negative in both tests 
(P>0.05). 
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Sepsis 
BERA 90 db 
OAE 
+ve -ve Total Test value +ve -ve Total 
Test 
value 
No 6 137 143 χ2=.000 25 118 143 χ2=0.000 
YES 0 1 1 df=1 1 0 1 df=1 
Total 6 138 144 P=1.00 26 118 144 P=1.00 
 
 
Table -9 shows the association between  positive and negative with 
Sepsis of BERA 90 and OAE. The results revealed that there was no sig-
nificant associated established either positive or negative in both tests 
(P>0.05). 
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Association between hearing loss and birth weight: 
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Birth 
weight 
BERA 90 db 
OAE 
+ve -ve Total Test value +ve -ve Total 
Test 
value 
Normal 6 131 137 χ2=.000 24 113 137 χ2=0.000 
Abnormal 0 7 7 df=1 2 5 7 df=1 
Total 6 138 144 P=1.00 26 118 108 P=1.00 
 
 
Table -10  shows the association between  positive and negative 
with birth weight of BERA 90 and OAE. The results revealed that there 
was no significant associated established either positive or negative in 
both tests (P>0.05). 
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Association between maturity and hearing loss 
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Term 
BERA 90 db 
OAE 
+ve -ve Total Test value +ve -ve Total 
Test 
value 
Full 
term 6 131 137 χ
2=.000 24 113 137 χ2=0.000 
Pre 
term 0 7 7 df=1 2 5 7 df=1 
Total 6 138 144 P=1.00 26 82 144 P=1.00 
 
Table -11 shows the association between positive and negative 
with term of BERA 90 and OAE. The results revealed that there was no 
significant associated established either positive or negative in both tests 
(P>0.05). 
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RESULTS 
 
Among the hundred and fifty babies screened, 26 failed OAE while 
6 failed BERA. 
Referral rate was 18.1% with OAE and 4.2% with BERA 
All 6 babies failed with 40db and 90 db screening.  
They failed in behaviour response audiometry done subsequently. 
BERA hence is considered gold standard in hearing screening. 
Mean duration of NICU stay had a positive correlation with BERA 
positivity. 
Average duration of BERA positive cases (15.3 days) was signifi-
cantly higher than BERA negative cases (11.3) 
Babies with higher duration of NICU stay had greater probability 
of hearing loss. 
Age and Sex had no significant correlation with hearing loss. 
One case with sepsis had hearing loss identified with OAE but it 
passed BERA in both ears. 
One case with history of ototoxic drug administration had the result  
REFER with OAE. But it passed BERA in both ears. 
Sensitivity of OAE as 16.7 % and the specificity was 81.9 %.  
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Positive likelihood ratio with OAE was .923 
Negative likelihood ratio with OAE was 1.02  
Among 6 cases with profound hearing loss one had neonatal    
jaundice. Two cases with hearing loss identified by OAE was preterm. 
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DISCUSSION 
OAE had a higher referral rate compared to BERA and since    
overall prevalence of deafness was 1.4 %, false positive results are      
significantly more with OAE.  Since referral leads to unwanted parental 
anxiety and and additional visits to higher institution for confirmatory   
audiometric investigation, BERA is a better tool for screening.  
All 6 babies identified with BERA failed with behaviour response 
audiometry too. But BERA was significantly difficult to perform and 
more expensive. 
Among 6 cases with profound hearing loss, one had neonatal  
jaundice.  
No significant correlation exists between hearing loss and the fol-
lowing factors -age, sex and maturity. 
Significant correlation exists between hearing loss and mean dura-
tion of NICU stay. 
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SUMMARY 
 
On summarising, the diagnostic ability of BERA is better than 
OAE . 
OAE has a higher false positive rate hence its use as a screening 
tool in NICU population is limited. 
BERA done at 40 and 90 dB have identical results hence making it 
gold standard in hearing screening. 
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CONCLUSION 
1. BERA is the gold standard in newborn hearing program 
2. OAE has higher referral rate and lower specificity compared to 
BERA. 
3. Cases with Neonatal jaundice, Birth Asphyxia, ototoxic drugs and 
sepsis have developed hearing loss.  
4. No significant association between Sex and Gestational age with 
hearing loss. 
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LIMITATIONS 
1. Limitations inherent to cross-sectional study exist in this study.  
2. Hearing screening needs proper follow-up and repeated testing at 3 
month and 6 month as BERA findings have been proven to be    
reversible in neonatal jaundice. 
3. Since prevalence of deafness is 1.6 %, identification of risk factors  
for deafness requires a larger study with wider set of inclusion    
criteria. 
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FUTURE RECOMMENDATIONS 
1. Data regarding Universal hearing screening and prevalence of 
deafness among healthy newborn is lacking in South Indian      
population. 
2. Cohort study with complete follow up till audiological recovery 
could be done with emphasis on the importance of early screening. 
This can be compared with cohort of unscreened babies with late 
audiological intervention and their handicaps. 
3. Larger sample size can be studied to analyse all the risk factors for 
hearing loss. Previous data has shown significant association      
between low birth weight birth asphyxia and neonatal jaundice. 
4. Extreme premature neonates should be studied separately owing to 
neurological immaturity of evoked responses. 
5. Newer modalities like Cortical evoked response audiometry (CE-
RA) could be explored. CERA is much easier to perform and fre-
quently used in adult hearing. Its relevance in newborn screening 
needs to be assessed. 
6. Importance of Behaviour response audiometry and possibility  of 
training paediatricians and NICU nurses in hearing assessment 
could be studied. This could be compared with regular program 
and feasibility trial could be done. This is essential in SNCUs and 
primary care set-up where proper audiological facility is a luxury. 
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7. Multiple protocols could be studied in Randomised controlled 
study- comparing 2 stage (OAE and BERA) and single stage 
screening. ABR and confirmatory BERA could be done and stu-
died at various levels. 
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ABBREVIATIONS 
BERA - Brainstem Evoked Response Audiometry 
OAE  - Oto-acoustic Emission 
ASSR - Auditory steady state response 
RBSK - Rashtriya Bal Swasthya Karyakram 
BOA  - Behavioural Observation Audiometry 
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ANNEXURE I - PROFORMA 
Name : 
Age : 
IP No : 
Study No : 
Address/Contact details : 
History 
Antenatal : 
  Fever 
Medications 
  Jaundice 
  Antibiotic 
Natal : 
  Birth weight   
  Term/Preterm 
  Birth Asphyxia 
  Mode of delivery 
Post natal :  
  NICU admission 
  Seizure 
  IV Antibiotics 
               Jaundice                       
               Lethargy   
 
Clinical Exam : 
Sensorium 
Jaundice 
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Pallor 
Head to foot : 
 Microcephaly 
               Sutures and Fontanelles  
               Facial dysmorphism 
 Cataract  
Ear anomalies :   
CNS : 
 Tone 
           Palpebral 
Moro 
Course during Hospital stay 
NICU   :            
Duration Mechanical ventilation Antibiotics  
   
 
Jaundice   : 
Peak serum bilirubin Phototherapy                            Exchange transfusion 
   
 
 RE LE 
TEOAE   
   
BERA    90 dB   
           40 dB   
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INFORMED CONSENT FORM 
Study place: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR 
CHILDREN, INSTITUTE OF OBSTETRICS AND GYNAECOLOGY 
Title of the study: DIAGNOSTIC ABILITY OF OTO-ACOUSTIC           
EMISSION AND BRAIN STEM EVOKED  RESPONSE             
AUDIOMETRY IN HEARING SCREENING OF HIGH RISK 
NEWBORN 
Name of the investigator  :  R.Karthik    
Name of the Participant:  Age:   Sex: 
Hospital number:   Study no: 
1. I have read and understood this consent form and the information pro-
vided to me regarding the participation in the study.  
2. I have had the consent document explained to me.  
3. I have been explained about the nature of the study.  
4. I have been explained about my rights and responsibilities by the in-
vestigator.  
5. I have informed the investigator of all the treatments I am taking or 
have taken in the past  
including any native (alternative) treatment.  
6. I have been advised about the risks associated with my participation in 
this study.* 
7. I agree to cooperate with the investigator and I will inform him/her 
immediately if I suffer  
unusual symptoms. * 
8. I have not participated in any research study in the past. 
10. I am aware of the fact that I can opt out of the study at any time with-
out having to give any reason  
and this will not affect my future treatment in this hospital. * 
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11. I am also aware that the investigator may terminate my participation 
in the study at any time, for  
any reason, without my consent. * 
12. I hereby give permission to the investigators to release the                
information obtained from me as result of participation in this study to the 
sponsors, regulatory authorities, Govt. agencies, and IEC.  I understand 
that they are publicly presented.  
13. I have understand that  my  identity will be kept confidential if my da-
ta are publicly presented  
14. I have had my questions answered to my satisfaction.  
15. I have decided to be in the research study.  
I am aware that if I have any question during this study, I should contact 
the investigator. By signing  
this consent form I attest that the information given in this document has 
been clearly explained to me  
and understood by me, I will be given a copy of this consent document. 
For adult participants:  
Name and signature / thumb impression of the participant 
/parents/guardian  
Name _________________________ Signature_________________ 
Date________________  
Name and Signature of impartial witness:  
Name _________________________ Signature_________________ 
Date________________ 
Name and Signature of the investigator or his representative obtaining 
consent:  
Name _________________________ Signature_________________ 
Date________________  
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INFORMATION SHEET 
 
Place of study: INSTITUTE OF CHILD HEALTH AND HOSPITAL FOR CHILDREN, IN-
STITUTE OF OBSTETRICS AND GYNAECOLOGY. 
Name of Investigator :  R.Karthik 
Name of Participant    age:   sex:  
Hospital No:     Study  No: 
Study title : DIAGNOSTIC ABILITY OF OTO-ACOUSTIC  EMIS-
SION AND BRAIN STEM EVOKED  RESPONSE AUDIOMETRY 
IN HEARINGSCREENING OF HIGH RISK NEWBORN•  
We are conducting a study on “DIAGNOSTIC ABILITY OF                   
OTO-ACOUSTIC  EMISSION AND BRAIN STEM EVOKED      
RESPONSE AUDIOMETRY IN HEARINGSCREENING OF HIGH 
RISK NEWBORN” 
We request you to participate in the study 
• The purpose of this study is to compare Oto-acoustic emission and Brainstem evoked re-
sponse audiometry in hearing screening in high risk newborn 
• The privacy of the patients in the research will be maintained throughout the study. In the 
event of any publication or presentation resulting from the research, no personally identifi-
able information will be shared. 
• Taking part in this study is voluntary. You are free to decide whether to participate in this 
study or to withdraw at any time; your decision will not result in any loss of benefits to which 
you are otherwise entitled. 
• The results of the special study may be intimated to you at the end of the study period or 
during the study if anything is found abnormal which may aid in the management or treat-
ment. 
 
 
 
Signature of investigator                                         Signature of participant/parent/guardian 
 
 
Date: 
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Name Days Sex NICU NNH Birth Asphyxia
Family 
history of 
hearing loss
Ototoxic 
drugs
Ear 
Anomalies Sepsis Birth weight Preterm  OAE left OAE right
BERA left 90 
db
BERA right 
90 db
BERA left 
40db
BERA right 
40 db
B/o Bhuvaneshwari 15 1 9 1 1 1 1 1 1 1 1 1 2 1 1 1 1
B/o Saraladevi 23 1 18 1 1 1 1 1 1 1 1 2 1 1 1 1 1
B/O Dhanalakshmi 22 2 20 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Saisaran 21 2 15 1 1 1 1 1 1 1 1 1 2 1 1 1 1
B/O Jayanthi 18 2 12 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/O Muthulakshmi 24 1 14 1 1 1 1 1 1 1 1 1 2 1 1 1 1
B/O Premila twin 1 21 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/O Premila twin 2 28 2 14 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Thasleem 16 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Ammu 10 2 9 1 1 1 1 1 1 1 1 2 1 2 2 2 2
Priya 15 2 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Nazeera 14 1 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
 B/o Lakshmi 10 1 8 1 1 1 1 1 1 1 1 1 2 2 2 2 2
B/o Tamilselvi 10 1 8 1 1 1 1 1 1 1 1 2 1 1 1 1 1
B/o Latha 7 2 6 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/o Nathiya 16 2 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Kalaiselvi 15 2 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Shobana 15 1 11 1 1 1 1 1 1 1 1 1 1 2 2 2 2
B/o Muthukamatchi 15 2 10 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Gomathi 27 2 21 1 1 1 1 1 1 1 1 2 2 2 2 2 2
B/o Karthika 30 2 21 1 1 1 1 1 1 1 1 2 2 2 2 2 2
B/o Tharamary 12 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Selvi 15 2 9 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Kalaiarasi Twin 1 23 1 14 1 1 1 1 1 1 1 1 1 1 1 1 1 1
MASTER CHART
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B/o Kalaiarasi Twin 2 23 1 16 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Saruna 28 1 19 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Kalavathy 9 2 7 2 1 1 1 1 1 2 2 1 1 1 1 1 1
B/o Geetha 10 2 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Parameshwari 30 1 23 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Renuka 9 1 7 2 1 1 1 1 1 2 2 1 1 1 1 1 1
B/o Uma Maheshwari 14 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Parimala 8 2 6 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Manju 12 1 11 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/o Sithiraikani 7 2 6 1 1 1 1 1 1 1 1 1 2 1 1 1 1
B/o Patchaiyammal 10 1 8 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Fathima 14 2 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Muniyammal 13 1 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Sharmila 8 1 6 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o devi 7 2 5 1 1 1 1 1 1 1 1 2 1 1 1 1 1
B/o Athilakshmi twinI 20 1 18 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Athilakshmi twin2 20 2 17 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/O Devi II 7 1 6 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/O Seethalakshmi 11 1 10 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/o Amudha 12 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Pencillama twin1 12 1 10 1 1 1 1 1 1 1 1 2 1 1 1 1 1
B/o Pencillama twin2 12 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Geetha 13 1 9 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Saranya 24 2 16 1 1 1 1 1 1 1 1 1 2 1 1 1 1
B/o Lakshmi 13 1 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Amudha II 10 1 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Ananthi 10 2 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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B/o Zahidha twin 1 22 2 18 1 1 1 1 1 1 1 1 1 2 1 1 1 1
B/o Zahidha twin 2 22 2 20 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Baby 9 2 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Radhika 14 1 11 1 1 1 1 1 1 1 1 2 1 1 1 1 1
B/o Arasu 21 2 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Renuka II 22 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Parameshwari 23 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o selvamani kumari 24 1 14 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Nathiya 18 1 13 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Karthiga 17 1 14 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Shobana 
Rajalakshmi
15 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Yalini 30 2 22 2 1 1 1 1 1 1 1 1 2 2 2 2 1
B/o Gomathy II 30 1 18 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/o Muthu 28 1 12 2 1 1 2 1 1 1 1 1 2 1 1 1 1
B/o draupathy 21 1 14 1 1 1 1 1 2 1 1 1 2 1 1 1 1
B/o Rajathi 20 2 21 2 1 1 1 1 1 1 2 1 1 1 1 1 1
B/o Vanitha 29 1 11 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Sasirekha 21 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Devi twin I 22 2 20 1 1 1 1 1 1 2 2 1 1 1 1 1 1
B/o Devi twin II 21 1 21 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Amudhamalar 18 1 17 1 1 1 1 1 1 2 1 2 2 1 1 2 2
B/o Sheik Afree 21 2 13 2 1 1 1 1 1 2 2 1 2 1 1 1 1
B/o Sailakshmi 19 1 18 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Adhisakthi 19 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Nahajabeen 21 1 18 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Naganna 20 1 16 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Sharnila 18 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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B/o Gayathri 17 2 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Saranya 13 1 6 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Aruna 8 1 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Rekha 10 2 8 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Helen jaya 11 1 7 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Parimala 2 twin 1 21 1 12 2 1 1 1 1 1 2 2 1 1 1 1 1 1
B/o Parvathy 22 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Ramya 28 1 13 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o mohanapriya 14 2 11 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/o Shakila 11 1 8 1 2 1 1 1 1 1 1 1 1 1 1 1 1
B/o Parveen 12 1 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Jamunarani 16 2 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Sarala 14 2 6 1 1 1 1 1 1 2 1 1 1 1 1 1 1
B/o Jansirani 12 1 8 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/o Sandhya triplet 1 13 1 7 2 1 1 1 1 1 1 2 1 1 1 1 1 1
B/o Sandhya triplet 2 13 1 7 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Sandhya triplet 3 13 1 7 2 1 1 1 1 1 1 1 1 1 1 1 1 1
Jabul nisha 16 2 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Jayashri 21 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Anandhi 20 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Athilakshmi 2 11 2 10 1 2 1 1 1 1 1 1 1 1 1 1 1 1
B/o Uma 23 1 8 1 1 1 1 1 1 1 1 2 2 1 1 1 1
B/o Saruna 19 1 9 1 2 1 1 1 1 1 1 1 1 1 1 1 1
B/o Kalaiarasi 2 18 1 7 1 1 1 2 1 1 1 1 1 1 1 1 1 1
B/o Thara 9 2 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Selvi 2 12 2 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o niranjana 9 2 7 2 1 1 1 1 1 1 1 1 1 1 1 1 1
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B/O veena 27 1 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o nandini 20 1 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o sowbagya 18 2 6 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o ashwini 13 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o malarvili 14 1 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o suganthi 30 2 23 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o jaya 23 1 13 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o jothi 22 2 20 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o chamundeeswari 9 1 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o harini 18 2 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o dharani 24 2 16 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o hemavathi 12 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o padmini 22 1 13 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o kamala 26 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o rajeswari 8 1 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o divyalakshmi 15 1 9 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o shandhi 16 2 9 2 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o pushpalatha 12 2 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o kalaivani 14 2 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/O Seetha 14 1 12 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o vimala 21 1 14 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Geetha II 25 1 18 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o valarmathi 11 2 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Kavitha 14 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Maria 15 1 10 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o banumathi 23 1 16 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Jansi 11 1 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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B/o punitha mary 13 2 9 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o lavanya 13 2 9 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o charumathy 8 1 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o Selvamani 9 2 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o thilagavathy 9 1 7 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o malli 12 2 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o gunamathi 21 1 16 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o raji 21 1 15 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o reena 24 2 17 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o vanmathi 30 2 19 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o ramani 11 1 9 1 1 1 1 1 1 1 1 1 1 1 1 1 1
B/o leelavathy 13 1 8 1 1 1 1 1 1 1 1 1 1 1 1 1 1
  
KEY TO MASTER CHART 
A.SEX 
 1 - Male 
 2 - Female 
B.NNH 
 1 - Neonatal hyperbilirubinemia absent 
 2 - Neonatal hyperbilirubinemia present 
C.Birth Asphyxia 
 1 - Birth Asphyxia absent 
 2 - Birth Asphyxia present 
D.Family history of hearing loss 
 1 - Family history of hearing loss absent 
 2 - Family history of hearing loss present 
E.Ototoxic drugs 
 1 - Ototoxic drugs not given 
 2 - Ototoxic drugs given 
  
  
F.Ear Anomalies 
 1 -  Ear Anomalies absent 
 2 - Ear Anomaliespresent 
G.Sepsis 
 1 - Sepsis absent 
 2 - Sepsis present 
H.Birth weight 
 1 - Normal Birth weight 
 2 - Low or Very Low birth weight 
I.Prematurity 
 1 - Term 
 2  - Premature 
 
J.OAE left ,OAE right, BERA left 90 db,BERA right 90 db,BERA 
left 40 db,BERA left 40 db 
 1 - Pass 
 2 - Refer 
 
